Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Hiroshi Fukase is active.

Publication


Featured researches published by Hiroshi Fukase.


Carbohydrate Research | 1985

Stereoselective conversion of valienamine and validamine into valiolamine

Satoshi Horii; Hiroshi Fukase; Yukihiko Kameda

Abstract Methods are described for the stereoselective conversion of valienamine ( 2 ) and validamine ( 3 ) into valiolamine ( 1a ), a new pseudo-amino sugar isolated from the fermentation broth of Streptomyces hygroscopicus subsp. limoneus and which is a stronger α- d -glucosidase inhibitor than 2 and 3 . Treatment of the acyclic carbamates ( 4 ) of 2 with halogenation reagents led to ring closure to afford the halo cyclic carbamates ( 6 ), which were reductively dehalogenated and then hydrolyzed to give 1a . Similar treatment of the exomethylene acyclic carbamate ( 12 ), derived from 3 via 8–11 , resulted in the formation of halo cyclic carbamates ( 14a,b ), which were converted into 1a . The synthesis of epivaliolamine ( 1b ), the C-1 epimer of 1a , starting from 2 and 3 , is also described.


Carbohydrate Research | 1978

A new method for selective N-acylation of aminoglycoside antibiotics

Satoshi Horii; Hiroshi Fukase; Yukihiko Kameda; Nariakira Mizokami

Abstract Per- N -formylation of aminoglycoside (aminocyclitol) antibiotics followed by mild hydrolysis with aqueous ammonia gave mono- N -deformylated derivatives. Each positional isomer of the mono- N -deformylated derivatives thus obtained was separated by column chromatography on Amberlite CG-50 (NH 4 + ). Acylation of mono- N -deformylated derivatives gave the corresponding mono- N -acylated derivatives. The N -formyl groups of the mono- N -acylates were removed by the treatment with dilute aqueous hydrazine acetate, whereas the newly introduced N -acyl group was stable under these conditions. The 1- N -formyl group of the deoxystreptamine moiety of per- N -formylated aminoglycoside antibiotics containing neamine (or 3′-deoxyneamine) is more readily deformylated than the 3- N -formyl group. In this report, isolation and structural-elucidation studies, including 13 C-n.m.r. spectral assignments, of positional isomers of tri- N -formyl derivatives of xylostasin ( 1 ), 3′-deoxyxylostasin ( 2 ), kanamycin A ( 3 ), and neamine ( 4 ) are described. This selective N -acylation provides a useful method for the preparation of 1- N -modified derivatives, and the synthesis of 3′-deoxybutirosin A ( 2f ) from 2 is described in detail as an example.


Journal of Medicinal Chemistry | 1986

Synthesis and .alpha.-D-glucosidase inhibitory activity of N-substituted valiolamine derivatives as potential oral antidiabetic agents

Satoshi Horii; Hiroshi Fukase; Takao Matsuo; Yukihiko Kameda; Naoki Asano; Katsuhiko Matsui


The Journal of Antibiotics | 1984

Valiolamine, a new alpha-glucosidase inhibiting aminocyclitol produced by Streptomyces hygroscopicus.

Yukihiko Kameda; Naoki Asano; Michiyo Yoshikawa; Masayoshi Takeuchi; Takuji Yamaguchi; Katsuhiko Matsui; Satoshi Horii; Hiroshi Fukase


Archive | 1981

N-substituted pseudo-aminosugars, their production and use

Satoshi Horii; Yukihiko Kameda; Hiroshi Fukase


Journal of Organic Chemistry | 1992

Synthesis of valiolamine and its N-substituted derivatives AO-128, validoxylamine G, and validamycin G via branched-chain inosose derivatives

Hiroshi Fukase; Satoshi Horii


The Journal of Antibiotics | 1986

VALIDAMYCIN G AND VALIDOXYLAMINE G, NEW MEMBERS OF THE VALIDAMYCINS

Yukihiko Kameda; Naoki Asano; Takuji Yamaguchi; Katsuhiko Matsui; Satoshi Horii; Hiroshi Fukase


Journal of Organic Chemistry | 1992

Synthesis of a branched-chain inosose derivative, a versatile synthon of N-substituted valiolamine derivatives from D-glucose

Hiroshi Fukase; Satoshi Horii


The Journal of Antibiotics | 1982

N-substituted valienamines, .ALPHA.-glucosidase inhibitors.

Yukihiko Kameda; Naoki Asano; Niichiyo Yoshikawa; Katsuhiko Matsui; Satoshi Horii; Hiroshi Fukase


The Journal of Antibiotics | 1976

C-2801X, A NEW CEPHAMYCIN-TYPE ANTIBIOTIC

Hiroshi Fukase; Toru Hasegawa; Kazunori Hatano; Hidesuke Iwasaki; Masahiko Yoneda

Collaboration


Dive into the Hiroshi Fukase's collaboration.

Top Co-Authors

Avatar

Satoshi Horii

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Hidesuke Iwasaki

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Eiji Higashide

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Kazunori Hatano

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Nariakira Mizokami

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Toru Hasegawa

Takeda Pharmaceutical Company

View shared research outputs
Researchain Logo
Decentralizing Knowledge